Cite
HARVARD Citation
Frezzato, F. et al. (2019). HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia. International journal of cancer. 145 (11), pp. 3089-3100. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Frezzato, F. et al. (2019). HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia. International journal of cancer. 145 (11), pp. 3089-3100. [Online].